PHAS
Nuveen Asset Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-80,353
| Closed | -$278K | – | 3503 |
|
|
2021
Q1 | $278K | Sell |
80,353
-18,503
| -19% | -$64K | ﹤0.01% | 3186 |
|
|
2020
Q4 | $332K | Buy |
98,856
+154
| +0.2% | +$517 | ﹤0.01% | 3118 |
|
|
2020
Q3 | $347K | Buy |
98,702
+66,347
| +205% | +$233K | ﹤0.01% | 3046 |
|
|
2020
Q2 | $149K | Sell |
32,355
-10,146
| -24% | -$46.7K | ﹤0.01% | 3134 |
|
|
2020
Q1 | $141K | Buy |
42,501
+5,488
| +15% | +$18.2K | ﹤0.01% | 3032 |
|
|
2019
Q4 | $226K | Sell |
37,013
-1,881
| -5% | -$11.5K | ﹤0.01% | 3064 |
|
|
2019
Q3 | $162K | Buy |
38,894
+3,719
| +11% | +$15.5K | ﹤0.01% | 3138 |
|
|
2019
Q2 | $462K | Buy |
+35,175
| New | +$462K | ﹤0.01% | 3021 |
|